Systemic metastasis-targeted nanotherapeutic reinforces tumor surgical resection and chemotherapy
Failure of conventional clinical therapies such as tumor resection and chemotherapy are mainly due to the ineffective control of tumor metastasis. Here, the authors show that a systemic metastasis-targeted nanotherapeutic may offer a powerful adjunct therapy for suppressing tumor metastasis.
Guardado en:
Autores principales: | Minjun Xu, Kaili Hu, Yipu Liu, Yukun Huang, Shanshan Liu, Yu Chen, Dayuan Wang, Songlei Zhou, Qian Zhang, Ni Mei, Huiping Lu, Fengan Li, Xiaoling Gao, Jun Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7a2d7bd07266424ab8d1204d7d93e358 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeted nanotherapeutics in cancer
por: Shiekh FA
Publicado: (2014) -
Smart Nanotherapeutics and Lung Cancer
por: Mohammad Doroudian, et al.
Publicado: (2021) -
Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment
por: Lin Tang, et al.
Publicado: (2021) -
Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer
por: Kamil D. Dalgatov, et al.
Publicado: (2021) -
Vascular targeted nanotherapeutic approach for obesity treatment
por: Sibuyi NRS, et al.
Publicado: (2018)